BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1 AND Treatment
23825 results:

  • 1. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
    Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
    Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
    Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
    Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Incidental Finding of an Asymptomatic Jejunal Schwannoma: A Rare Case Report and Review of Literature.
    Katsiafliaka K; Karlafti E; Tzikos G; Goulas P; Zatagias A; Vouchara A; Psoma E; Tsakona A; Petrakis G; Paramythiotis D
    Am J Case Rep; 2024 May; 25():e942881. PubMed ID: 38745406
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Leg skin ulcer with atypical features: vascular wound or advanced melanoma?
    Monari P; Galli B; Pinton PC
    Wounds; 2024 Apr; 36(4):119-123. PubMed ID: 38743857
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.
    Sobczyk P; Sobstyl M; Acewicz A; Rosa J; Grabiec M; Grajkowska W
    Folia Neuropathol; 2024; 62(1):96-101. PubMed ID: 38741436
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
    da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
    Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
    Stoyukhina AS
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Repeat Radiosurgery for Sporadic Vestibular Schwannoma After Primary Radiosurgical Failure: An International Multi-institutional Investigation.
    Khandalavala KR; Herberg HA; Kay-Rivest E; Moore LS; Yancey KL; Marinelli JP; Lund-Johansen M; Kosaraju N; Lohse CM; Kutz W; Santa Maria PL; Golfinos JG; Kondziolka D; Carlson ML; Tveiten ØV; Link MJ
    Otol Neurotol; 2024 Jun; 45(5):587-593. PubMed ID: 38728563
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Glioma.
    Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
    Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
    Lin H; Liu C; Hu A; Zhang D; Yang H; Mao Y
    J Hematol Oncol; 2024 May; 17(1):31. PubMed ID: 38720342
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors.
    Falkman L; Sundin A; Skogseid B; Botling J; Bernardo Y; Wallin G; Zhang L; Welin S; Lase I; Mollazadegan K; Crona J
    Ups J Med Sci; 2024; 129():. PubMed ID: 38716076
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
    Moser JC; Bhatia S; Amin A; Pavlick AC; Betts KA; Du EX; Poretta T; Shelley K; Srinivasan S; Sakkal LA; Palaia J; Lobo M; Pe Benito M; Linton JA; Chen Y; Xu C; Yin L; Sundar M; Weber J
    Cancer Immunol Immunother; 2024 May; 73(7):116. PubMed ID: 38713408
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.
    Yuan J; Siakallis L; Li HB; Brandner S; Zhang J; Li C; Mancini L; Bisdas S
    BMC Med Imaging; 2024 May; 24(1):104. PubMed ID: 38702613
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.
    Syc-Mazurek SB; Zhao-Fleming H; Guo Y; Tisavipat N; Chen JJ; Zekeridou A; Kournoutas I; Orme JJ; Block MS; Lucchinetti CF; Mustafa R; Flanagan EP
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200249. PubMed ID: 38696737
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Characterizing the presentation, management, and clinical outcomes of patients with intradural spinal chordomas: a systematic review.
    Saint-Germain MA; Kramer P; Weber-Levine C; Jiang K; Al-Mistarehi AH; Redmond KJ; Lee SH; Bettegowda C; Theodore N; Lubelski D
    Neurosurg Focus; 2024 May; 56(5):E14. PubMed ID: 38691865
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A comparison of endoscopic endonasal versus open approaches for skull base chordoma: a comprehensive National Cancer Database analysis.
    Soffer JM; Ulloa R; Chen S; Ziltzer RS; Patel VA; Polster SP
    Neurosurg Focus; 2024 May; 56(5):E5. PubMed ID: 38691856
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Long-term outcome of primary clival chordomas: a single-center retrospective study with an emphasis on the timing of recurrences based on the primary treatment.
    Hong S; Shinya Y; Mahajan A; Laack NN; O'Brien EK; Stokken JK; Janus JR; Raghunathan A; Link MJ; Van Gompel JJ
    Neurosurg Focus; 2024 May; 56(5):E4. PubMed ID: 38691852
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Case report: Temozolomide induced hypermutation indicates an unfavorable response to immunotherapy in patient with gliomas.
    Liu J; Hu S; Jiang H; Cui Y
    Front Immunol; 2024; 15():1369972. PubMed ID: 38690285
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Analysis of clinical manifestations and imaging features of facial nerve schwannomas].
    Han Y; Liu H; Yang R; Li R; Liu X; Wang W; Zhang J; Dong J; Zha D
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 May; 38(5):380-385. PubMed ID: 38686473
    [No Abstract]    [Full Text] [Related]  

  • 20. [Analysis of the effect of different facial nerve managements applied to tumor resection in the jugular foramen region].
    Yin Y; Zhao Y; Tian X; Zhao Y; Chen H; Zhang L; Gao Z; Feng G
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 May; 38(5):368-371;375. PubMed ID: 38686470
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 1192.